A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)

This is an observational study designed to follow patients with metastatic or locally advanced and unresectable CRC or locally advanced or metastatic NSCLC (excluding predominant squamous histology) who are receiving Avastin in combination with first-line chemotherapy. Second-line metastatic CRC patients are also eligible. Patients who started their Avastin containing therapy <4 months prior to enrollment are eligible.

本研究为一项观察性研究，旨在随访患有转移性或局部晚期不可切除结直肠癌（Colorectal Cancer, CRC）、或排除主要鳞状细胞组织学亚型的局部晚期或转移性非小细胞肺癌（Non-Small Cell Lung Cancer, NSCLC），且正在接受贝伐珠单抗（Avastin）联合一线化疗方案治疗的患者。二线转移性结直肠癌患者同样符合入组条件。入组前4个月内启动含Avastin治疗方案的患者均可纳入本研究。